
Oncologists are exploring new biomarker-driven approaches, combination therapies, and sequencing strategies to improve outcomes for patients with esophageal and gastric cancers.


coremsg

Drs Samuel Klempner and Haeseong Park discuss emerging biomarkers and novel therapies for esophageal cancer, including new data from ASCO.

Episode 5: Emerging Biomarkers and Therapies for Esophageal Cancer

emerging-biomarkers-and-targeted-therapies-for-esophageal-and-gastric-cancers-insights-from-leading-oncologists


Emerging Biomarkers and Targeted Therapies for Esophageal and Gastric Cancers: Insights from Leading Oncologists
